GlassScriptPhysician profile
Kimberly S Wallace
NPI 1770627705
$9,287.53
in general payments reported to CMS, 2019-2025
48 companies · $1,928 in 2025
The $1,928 reported for 2025 was more than what 95% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,281 · 2020: $545 · 2021: $810 · 2022: $1,431 · 2023: $1,750 · 2024: $1,542 · 2025: $1,928.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,220.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,367.90 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Novo Nordisk INC | $1,201.07 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $820.98 | 2019-2025 | |
| Amgen INC. | $752.19 | 2019-2025 | Evenity, Prolia, Repatha |
| Lilly USA, LLC | $599.09 | 2019-2025 | Mounjaro, Zepbound, Kisunla |
| Astrazeneca Pharmaceuticals LP | $582.13 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Glaxosmithkline, LLC. | $317.47 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Merck Sharp & Dohme LLC | $253.99 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Exact Sciences Corporation | $248.71 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $196.02 | 2019-2025 | Jardiance, Tradjenta |
| Bayer Healthcare Pharmaceuticals INC. | $186.49 | 2022-2025 | |
| Horizon Therapeutics Plc | $166.16 | 2019-2023 | Krystexxa |
| Tris Pharma INC | $162.71 | 2022-2025 | Dyanavel Xr |
| Allergan, INC. | $158.33 | 2019-2020 | |
| Astellas Pharma US INC | $144.36 | 2021-2025 | Veozah |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Wallace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.